Jing Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jing Liu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Baiba Kurins Gillard
Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, TX 77030, USA
2 shared publications Dedipya Yelamanchili
Center for Bioenergetics, Houston Methodist, 6565 Fannin Street, Houston TX 77030, USA
2 shared publications- Henry J. Pownall
Center for Bioenergetics, Department of Medicine, Houston Methodist Research Institute, Houston, TX, USA; Weill Cornell Medicine, 1300 York Avenue, New York, NY
2 shared publications - Antonio M GottoJr
Weill Medical College, Cornell University, New York, NY 10065, USA
1 shared publication Antonio M. Gotto
Center for Bioenergetics, Houston Methodist Research Institute, TX (J.L., B.K.G., D.Y., A.M.G., C.R., H.J.P.).
1 shared publicationCorina Rosales
Center for Bioenergetics, Houston Methodist Research Institute, TX (J.L., B.K.G., D.Y., A.M.G., C.R., H.J.P.).
1 shared publication
Latest Publications
- Open Access
- 10 October 2023
- Published by Elsevier in Journal of Lipid Research
- Vol. 64 (11) , 100456
Serum opacity factor normalizes erythrocyte morphology in Scarb1−/− mice in an HDL-free cholesterol-dependent way
- 10 October 2023
- Published by Elsevier in Journal of Lipid Research
- Vol. 64 (11) , 100456
Open AccessSerum opacity factor normalizes erythrocyte morphology in Scarb1−/− mice in an HDL-free cholesterol-dependent way
- 1 October 2021
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 41 (10) , E453-E467
High Free Cholesterol Bioavailability Drives the Tissue Pathologies in Scarb1 −/− Mice
Objective: Overall and atherosclerosis-associated mortality is elevated in humans with very high HDL (high-density lipoprotein) cholesterol concentrations. Mice with a deficiency of the HDL receptor, Scarb1 (scavenger receptor class B type 1), are a robust model of this phenotype and exhibit several additional pathologies. We hypothesized that the previously reported high plasma concentration of free cholesterol (FC)–rich HDL in Scarb1 −/ − mice produces a state of high HDL-FC bioavailability that increases whole-body FC and dysfunction in multiple tissue sites. Approach and Results: The higher mol% FC in Scarb1 −/− versus WT (wild type) HDL (41.1 versus 16.0 mol%) affords greater FC bioavailability for transfer to multiple sites. Plasma clearance of autologous HDL-FC mass was faster in WT versus Scarb1 −/− mice. FC influx from Scarb1 −/− HDL to LDL (low-density lipoprotein) and J774 macrophages was greater (≈4×) than that from WT HDL, whereas FC efflux capacity was similar. The higher mol% FC of ovaries, erythrocytes, heart, and macrophages of Scarb1 −/− versus WT mice is associated with previously reported female infertility, impaired cell maturation, cardiac dysfunction, and atherosclerosis. The FC contents of other tissues were similar in the two genotypes, and these tissues were not associated with any overt pathology. In addition to the differences between WT versus Scarb1 −/− mice, there were many sex-dependent differences in tissue-lipid composition and plasma FC clearance rates. Conclusions: Higher HDL-FC bioavailability among Scarb1 −/− versus WT mice drives increased FC content of multiple cell sites and is a potential biomarker that is mechanistically linked to multiple pathologies.
- 1 October 2021
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 41 (10) , E453-E467
High Free Cholesterol Bioavailability Drives the Tissue Pathologies in Scarb1 −/− Mice
Objective: Overall and atherosclerosis-associated mortality is elevated in humans with very high HDL (high-density lipoprotein) cholesterol concentrations. Mice with a deficiency of the HDL receptor, Scarb1 (scavenger receptor class B type 1), are a robust model of this phenotype and exhibit several additional pathologies. We hypothesized that the previously reported high plasma concentration of free cholesterol (FC)–rich HDL in Scarb1 −/ − mice produces a state of high HDL-FC bioavailability that increases whole-body FC and dysfunction in multiple tissue sites. Approach and Results: The higher mol% FC in Scarb1 −/− versus WT (wild type) HDL (41.1 versus 16.0 mol%) affords greater FC bioavailability for transfer to multiple sites. Plasma clearance of autologous HDL-FC mass was faster in WT versus Scarb1 −/− mice. FC influx from Scarb1 −/− HDL to LDL (low-density lipoprotein) and J774 macrophages was greater (≈4×) than that from WT HDL, whereas FC efflux capacity was similar. The higher mol% FC of ovaries, erythrocytes, heart, and macrophages of Scarb1 −/− versus WT mice is associated with previously reported female infertility, impaired cell maturation, cardiac dysfunction, and atherosclerosis. The FC contents of other tissues were similar in the two genotypes, and these tissues were not associated with any overt pathology. In addition to the differences between WT versus Scarb1 −/− mice, there were many sex-dependent differences in tissue-lipid composition and plasma FC clearance rates. Conclusions: Higher HDL-FC bioavailability among Scarb1 −/− versus WT mice drives increased FC content of multiple cell sites and is a potential biomarker that is mechanistically linked to multiple pathologies.